iShares Biotechnology ETF (IBB)
BlackRock / iShares
- Page updated:
- Sep 7, 2026
- Data as of:
- Sep 3, 2026
Fund identity
- Ticker
- IBB
- Fund name
- iShares Biotechnology ETF
- Fund type
- ETF
- Listing venue
- NASDAQ
- Currency
- USD
- Domicile
- US
- Inception
- Feb 5, 2001
Structure and strategy
- Sponsor
- BlackRock / iShares
- Management approach
- Passive
- Strategy
- Tracks U.S.-listed biotechnology companies.
- Portfolio scope
- Biotechnology equities
- Portfolio implementation
- Index tracking
- Benchmark
- NYSE Biotechnology Index
- Benchmark symbol
- ICEBIOT
- Asset class
- Equity
- Category
- Biotechnology
Costs and minimums
- Net expense ratio
- 0.44%
- Expense ratio
- 0.44%
- Ongoing fee as of
- Sep 7, 2026
Size and distributions
- Assets under management
- $10.79B
- Assets under management scope
- Fund
- Distribution frequency
- Quarterly
Sources
- iShares Biotechnology ETF — issuer product page — BlackRock / iShares · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.